​

Funding Round

Series B - Perceive Biotherapeutics

Series B - Perceive Biotherapeutics

Investment Firm

Overview

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

Announced Date

Jan 05, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Retinal Degeneration Fund

Retinal Degeneration Fund

No designation

Participant Investors

4

Investor Name
Participant InvestorRetinal Degeneration Fund
Participant InvestorBraidwell
Participant InvestorCatalio Capital Management
Participant InvestorDeerfield

Round Details and Background

Perceive Biotherapeutics raised $78000000 on 2023-01-05 in Series B

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 05, 2023
Series B - Perceive Biotherapeutics
5-78.0M

Recent Activity

There is no recent news or activity for this profile.